Today, the ordinary shares of Tree of Knowledge International Corporation were cross listed on the USD Equities Market of the Jamaica Stock Exchange (JSE). Tree of Knowledge International was listed under the symbol TOKI. TOKI is listed at a price of US$0.0105 and brings to seventeen, the number of securities listed on the JSE’s US Dollar Market.
Mrs. Marlene Street Forrest, Managing Director of the JSE, commenting on TOKI’s listing stated, “The listing of Tree of Knowledge International Corporation has come into being due to the hard work we have been doing in Canada. The groundwork that we have been doing is bearing fruits and we are expecting to see further deepening of our association with Canadian companies in the future and between the Canadian market and the JSE. In spite of the challenging times, we are seeing some very positive results and I am encouraging Jamaicans to continue to look to the markets for wealth creation as exciting times are ahead. Collaborating with the Canadian market will expose Jamaicans to a wide variety of securities, which will no doubt increase liquidity on the local market and bring a wider range of choices to our local investors.”
“This listing has a very special meaning to MH&CO especially in light of the fact that the firm was instrumental in enabling securities to be cross-listed between the JSE and Canadian Stock Exchange and thereafter, to be the firm to handle the historic first cross-listing from a Canadian Stock Exchange to the JSE, which is also the first cannabis stock to list on the JSE as well. This is a game changer for the JSE and potentially a whole new line of business. Congratulations to Tree of Knowledge and to the JSE!” stated Mr. Matthew Hogarth, Managing Partner at MH&CO Attorneys-at-Law.
Tree of Knowledge International Corp (TOKI) is currently listed on the Canadian Securities Exchange and has three primary business segments: (1) Multidisciplinary specialty pain clinics with a focus on the treatment of chronic pain, including controlled applications of medical cannabis in Canada. Through an exclusive strategic alliance with Jack Nathan Medical Inc., the Company has access to one of the largest healthcare systems across Canada and internationally for its education and research platform (currently over 1.5 million patients visit annually); (2) Development of formulated products for therapeutic purposes and natural health product alternatives at its manufacturing facility in Spokane. The Company also has research agreements with multiple universities for medical cannabis research and development of new medical grade products; and (3) Distribution and sale of hemp-based Cannabidiol (“CBD”) products in the United States, Canada, Europe, Brazil and China. The CBD product line contains EVR Premium Hemp Oil, which is organically grown and non-GMO.
CONTACT:
NEVILLE ELLIS
Manager – Marketing & Communications
Telephone: 876-967-3271 (O) 876-322-0984 (C)
